Gemtuzumab ozogamicin, Antibody Drug Conjugate  Broad approval covering front-line & relapse settings

Gemtuzumab ozogamicin, Antibody Drug Conjugate Broad approval covering front-line & relapse settings

hematologydebates

2 years
58 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Amer M Zeidan, MBBS, Gemtuzumab ozogamicin, Antibody Drug Conjugate Broad approval covering front-line & relapse settings at Imedex Great Debates 2018
Up Next Autoplay